NLRP1 and Alzheimer disease: Our results suggested that inhibition of NLRP1 inflammasome activation might reverse the AMPK/mTOR pathway-mediated autophagy dysfunction, resulting in reduction of Aβ generation and deposition and ameliorating the pathological process of AD.